Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) VP Sergio Garcia sold 20,000 shares of the firm’s stock in a transaction on Monday, October 17th. The stock was sold at an average price of $39.08, for a total value of $781,600.00. Following the sale, the vice president now directly owns 86,241 shares of the company’s stock, valued at $3,370,298.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) opened at 39.30 on Wednesday. The stock has a market capitalization of $1.56 billion, a price-to-earnings ratio of 59.10 and a beta of 0.79. Zeltiq Aesthetics Inc. has a one year low of $18.41 and a one year high of $41.48. The company’s 50 day moving average price is $39.28 and its 200 day moving average price is $32.65.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last issued its earnings results on Monday, August 8th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.07. The business had revenue of $89.50 million for the quarter, compared to the consensus estimate of $79.68 million. Zeltiq Aesthetics had a net margin of 9.54% and a negative return on equity of 9.90%. The business’s revenue was up 38.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.03 EPS. On average, analysts expect that Zeltiq Aesthetics Inc. will post ($0.13) earnings per share for the current fiscal year.
ZLTQ has been the subject of several research reports. Stifel Nicolaus raised their price objective on Zeltiq Aesthetics from $38.00 to $52.00 and gave the stock a “buy” rating in a research note on Wednesday, September 21st. Leerink Swann reissued a “buy” rating on shares of Zeltiq Aesthetics in a research note on Thursday, June 30th. Brean Capital reissued a “buy” rating and set a $35.00 price objective on shares of Zeltiq Aesthetics in a research note on Tuesday, June 21st. Maxim Group raised their target price on Zeltiq Aesthetics from $40.00 to $48.00 and gave the stock a “buy” rating in a research report on Tuesday, August 9th. Finally, Zacks Investment Research raised Zeltiq Aesthetics from a “sell” rating to a “hold” rating in a research report on Saturday, July 23rd. Three equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $39.89.
Hedge funds have recently modified their holdings of the stock. Texas Permanent School Fund acquired a new stake in shares of Zeltiq Aesthetics during the first quarter valued at approximately $695,000. Prudential Financial Inc. acquired a new stake in shares of Zeltiq Aesthetics during the first quarter valued at approximately $2,049,000. BlackRock Group LTD boosted its stake in shares of Zeltiq Aesthetics by 278.1% in the first quarter. BlackRock Group LTD now owns 30,785 shares of the company’s stock valued at $837,000 after buying an additional 22,642 shares during the last quarter. BlackRock Fund Advisors boosted its stake in shares of Zeltiq Aesthetics by 134.5% in the first quarter. BlackRock Fund Advisors now owns 2,098,036 shares of the company’s stock valued at $56,983,000 after buying an additional 1,203,254 shares during the last quarter. Finally, Menta Capital LLC boosted its stake in shares of Zeltiq Aesthetics by 43.2% in the first quarter. Menta Capital LLC now owns 31,500 shares of the company’s stock valued at $856,000 after buying an additional 9,500 shares during the last quarter.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
Receive News & Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.